Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 6.75
0.00 (0.00%)
At close: Dec 5, 2025
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 29.25 million as of December 5, 2025. Its market cap has increased by 4.76% in one year.
Market Cap
29.25M
Enterprise Value
28.36M
Revenue
8.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.75
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 29.25M, a decrease of -71.03%. That is a compound annual growth rate of -22.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.25M | -2.00% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | 90.44M | -10.43% |
| Dec 15, 2020 | 100.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.00B |
| GSK plc | 73.57B |
| Haleon | 32.85B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |